Completed PHASE4 INTERVENTIONAL 2-arm
NCT06535360
Efficacy of Pathogen Inactivation Strategies for Platelet Transfusion
Improving Efficacy and Safety of Pathogen Inactivation Strategies for Platelet Transfusion in Cardiac Surgical Patients on Cardiopulmonary Bypass
Sponsor: University of Maryland, Baltimore
Conditions
Cardiopulmonary Bypass Surgery
Interventions
Platelet transfusion
Updated 1 time since 2024 Last updated: Aug 2, 2024 Started: Sep 1, 2020 Primary completion: May 31, 2023 Completion: May 31, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE4 clinical study on Cardiopulmonary Bypass Surgery, this trial is completed. The trial is conducted by University of Maryland, Baltimore and has accumulated 1 data snapshot since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Completed — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- University of Maryland, Baltimore
Data source: University of Maryland, Baltimore
For direct contact, visit the study record on ClinicalTrials.gov .